CDH1 germline mutations and hereditary lobular breast cancer

Familial Cancer

Volumn 15, Issue 2, 2016, Pages 215-219

  Corso, Giovanni ^a   Intra, Mattia ^a   Trentin, Chiara ^a   Veronesi, Paolo ^a   Galimberti, Viviana ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

E cadherin germline mutation; Hereditary breast cancer; Lobular breast cancer

Indexed keywords

SIGNAL PEPTIDE; UVOMORULIN; CADHERIN; CDH1 PROTEIN, HUMAN;

AMINO ACID SUBSTITUTION; BREAST CALCIFICATION; BREAST CANCER; BREAST CARCINOMA; BREAST RECONSTRUCTION; CANCER PREVENTION; CANCER STAGING; DISSECTION; EXON; FAMILIAL CANCER; FAMILY HISTORY; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC SCREENING; GERMLINE MUTATION; HEREDITARY LOBULAR BREAST CANCER; HETEROZYGOTE; HUMAN; MAMMOGRAPHY; MASTECTOMY; MISSENSE MUTATION; MUTATION RATE; MUTATIONAL ANALYSIS; NIPPLE SPARING MASTECTOMY; PEDIGREE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SENSITIVITY AND SPECIFICITY; SKIN INCISION; SPLICING DEFECT; STOMACH CANCER; STOP CODON; SURGICAL TECHNIQUE; TUMOR CALCINOSIS; BREAST NEOPLASMS; CARCINOMA, LOBULAR; FEMALE; GENETIC PREDISPOSITION; GENETICS;

BREAST NEOPLASMS; CADHERINS; CARCINOMA, LOBULAR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; MUTATION RATE;

EID: 84954312306     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-016-9869-5     Document Type: Review

References (37)

1. Berx G, Cleton-Jansen AM, Nollet F et al (1995) E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 14:6107–6115
2. Takeichi M (1991) Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251:1451–1455
3. Takeichi M, Hirano S, Matsuyoshi N, Fujimori T (1992) Cytoplasmic control of cadherin-mediated cell–cell adhesion. Cold Spring Harb Symp Quant Biol 57:327–334
4. Christofori G, Semb H (1999) The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 24:73–76. doi:10.1016/S0968-0004(98)01343-7
5. Corso G, Carvalho J, Marrelli D et al (2013) Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer. J Clin Oncol 31:868–875. doi:10.1200/JCO.2012.44.4612
6. Caldas C, Carneiro F, Lynch HT et al (1999) Familial gastric cancer: overview and guidelines for management. J Med Genet 36:873–880. doi:10.1136/jmg.36.12.873
7. Guilford P, Hopkins J, Harraway J et al (1998) E-cadherin germline mutations in familial gastric cancer. Nature 392:402–405
8. Corso G, Marrelli D, Pascale V, Vindigni C, Roviello F (2012) Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature. BMC Cancer 12:8. doi:10.1186/1471-2407-12-8
9. Keller G, Vogelsang H, Becker I et al (1999) Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol 155:337–342. doi:10.1016/S0002-9440(10)65129-2
10. Benusiglio PR, Malka D, Rouleau E et al (2013) CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study. J Med Genet 50:486–489. doi:10.1136/jmedgenet-2012-101472
11. Petridis C, Shinomiya I, Kohut K et al (2014) Germline CDH1 mutations in bilateral lobular carcinoma in situ. Br J Cancer 110:1053–1057. doi:10.1038/bjc.2013.792
12. Silva R, Susy C, Carneiro F, Amendoeira I (2014) Genetic profile and morphological features of breast cancers in the setting of Hereditary Breast Cancer (HBC) syndrome. Virchows Arch 465(Suppl 1):S111–S112
13. Rahman N, Stone JG, Coleman G et al (2000) Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene. Br J Cancer 82:568–570. doi:10.1054/bjoc.1999.0965
14. Masciari S, Larsson N, Senz J et al (2007) Germline E-cadherin mutations in familial lobular breast cancer. J Med Genet 44:726–731. doi:10.1136/jmg.2007.051268
15. Schrader KA, Masciari S, Boyd N et al (2011) Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers. J Med Genet 48:64–68. doi:10.1136/jmg.2010.079814
16. Xie ZM, Li LS, Laquet C et al (2011) Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer. Cancer 117:3112–3117. doi:10.1002/cncr.25876
17. Lei H, Sjöberg-Margolin S, Salahshor S et al (2002) CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk. Int J Cancer 98:199–204. doi:10.1002/ijc.10176
18. van der Post RS, Vogelaar IP, Carneiro F et al (2015) Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet 52:361–374. doi:10.1136/jmedgenet-2015-103094
19. Corso G, Figueiredo J, Biffi R et al (2014) E-cadherin germline mutation carriers: clinical management and genetic implications. Cancer Metastasis Rev 33:1081–1094. doi:10.1007/s10555-014-9528-y
20. Cataliotti L, Galimberti V, Mano MP (2010) The nipple sparing mastectomy (NSM). Attualità Senologia 59:11–20
21. Petit JY, Veronesi U, Lohsiriwat V et al (2011) Nipple-sparing mastectomy-is it worth the risk? Nat Rev Clin Oncol 8:742–747. doi:10.1038/nrclinonc.2011.159
22. Porter AJ, Evans EB, Foxcroft LM, Simpson PT, Lakhani SR (2014) Mammographic and ultrasound features of invasive lobular carcinoma of the breast. J Med Imaging Radiat Oncol 58:1–10. doi:10.1111/1754-9485.12080
23. Moll R, Mitze M, Frixen UH, Birchmeier W (1993) Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 143:1731–1742
24. Yeatman TJ, Cantor AB, Smith TJ et al (1995) Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg 222:549–559 (discussion 559–561)
25. Le Gal M, Ollivier L, Asselain B et al (1992) Mammographic features of 455 invasive lobular carcinomas. Radiology 185:705–708
26. Brem RF, Ioffe M, Rapelyea JA et al (2009) Invasive lobular carcinoma: detection with mammography, sonography, MRI, and breast-specific gamma imaging. AJR Am J Roentgenol 192:379–383. doi:10.2214/AJR.07.3827
27. Mann RM, Hoogeveen YL, Blickman JG, Boetes C (2008) MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature. Breast Cancer Res Treat 107:1–14. doi:10.1007/s10549-007-9528-5
28. Selinko VL, Middleton LP, Dempsey PJ (2004) Role of sonography in diagnosing and staging invasive lobular carcinoma. J Clin Ultrasound 32:323–332. doi:10.1002/jcu.20052
29. Krecke KN, Gisvold JJ (1993) Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients. AJR Am J Roentgenol 161:957–960
30. Berg WA, Gutierrez L, NessAiver MS et al (2004) Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233:830–849. doi:10.1148/radiol.2333031484
31. Tan SM, Behranwala KA, Trott PA et al (2002) A retrospective study comparing the individual modalities of triple assessment in the pre-operative diagnosis of invasive lobular breast carcinoma. Eur J Surg Oncol 28:203–208. doi:10.1053/ejso.2001.1236
32. Watermann DO, Tempfer C, Hefler LA, Parat C, Stickeler E (2005) Ultrasound morphology of invasive lobular breast cancer is different compared with other types of breast cancer. Ultrasound Med Biol 31:167–174. doi:10.1016/j.ultrasmedbio.2004.11.005
33. Lei J, Yang P, Zhang L, Wang Y, Yang K (2014) Diagnostic accuracy of digital breast tomosynthesis versus digital mammography for benign and malignant lesions in breasts: a meta-analysis. Eur Radiol 24:595–602. doi:10.1007/s00330-013-3012-x
34. Oliveira TM, Elias J Jr, Melo AF et al (2014) Evolving concepts in breast lobular neoplasia and invasive lobular carcinoma, and their impact on imaging methods. Insights Imaging 5:183–194. doi:10.1007/s13244-014-0324-6
35. Muttalib M, Ibrahem R, Khashan AS, Hajaj M (2014) Prospective MRI assessment for invasive lobular breast cancer. Correlation with tumour size at histopathology and influence on surgical management. Clin Radiol 69:23–28. doi:10.1016/j.crad.2013.07.016
36. Hansford S, Kaurah P, Li-Chang H et al (2015) Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond. JAMA Oncol 1(1):23–32. doi:10.1001/jamaoncol.2014.168
37. Mateus AR, Seruca R, Machado JC et al (2007) EGFR regulates RhoA-GTP dependent cell motility in E-cadherin mutant cells. Hum Mol Genet 16:1639–1647. doi:10.1093/hmg/ddm113